HB0491

AN ACT to amend Tennessee Code Annotated, Title 20 and Title 33, relative to opioids.

Complete·5/13/25

Amends Tennessee opioid-related laws to include additional pharmaceutical companies.

This bill amends Tennessee Code Annotated, Title 20 and Title 33, to include Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., and Sun Pharmaceutical Industries, Inc. in opioid-related regulations previously applying only to The Kroger Co. The changes ensure these companies are subject to the same requirements as The Kroger Co. The act also includes a severability clause, ensuring that if any part of the act is found invalid, the rest remains in effect. This act takes effect immediately upon becoming law.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Sponsors

0
2
RR
Democratic CaucusRepublican Caucus

Roll Call Votes

26 Yea

DDRRRRRRDRRDRRRDDRRDRRRRRR

0 Nay

Calendar

Apr 7, 2025

12:00 PM

House Private Acts Committee Hearing

Apr 2, 2025

12:00 PM

House Judiciary Committee Hearing

History

May 13, 2025

Comp. became Pub. Ch. 302

Apr 16, 2025

House

Comp. SB subst.

Apr 16, 2025

House

Sponsor(s) Added.